Crohn’s Disease

April 28, 2015April 28, 2015

Qu Biologics Enrolling Patients in Crohn’s Clinical Trials

Crohn's Disease, News

Biotechnology company Qu Biologics Inc. will initiate patient enrollment for two new clinical trials to evaluate a therapy for Crohn’s disease. The company is studying the use of its Site Specific Immunomodulators ... Read more

April 20, 2015April 27, 2015

Crohn’s Disease Researcher Raja Atreya Awarded Paul Ehrlich and Ludwig Darmstaedter Prize

Crohn's Disease, News

The 2015 €60,000 Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers has been awarded to Professor Raja Atreya from Medical Clinic 1 of the Erlangen University Hospital who has ... Read more

April 17, 2015September 28, 2016

FDA Authorizes Soligenix’s Pivotal Phase 3 Clinical Trial for Pediatric Crohn’s Disease Therapy

Crohn's Disease, News

Biopharmaceutical company Soligenix, Inc. recently announced in a news release that the U.S. Food and Drug Administration (FDA) has authorized a pivotal Phase 3 clinical trial to assess the efficacy ... Read more

April 9, 2015April 9, 2015

Stem Cells Heal Crohn’s Fistula in Clinical Trial

Crohn's Disease, News

Patients with Crohn’s fistula may benefit from therapy with autologous adipose-derived stem cells (ASCs), according to the results of a phase 2 clinical trial conducted by five medical institutions in collaboration ... Read more

March 30, 2015March 30, 2015

US and Canadian Healthcare Systems Can Implement Smoking Cessation Programs to Address Crohn’s Disease

Crohn's Disease, News

Researchers from the Institute for Public Health, University of Calgary, Canada, recently released findings from a study in which they performed a cost-utility analysis of funding smoking cessation programs for patients ... Read more

March 26, 2015September 28, 2016

Mongersen Shows Promise for Crohn’s Disease

Colon Cancer, Crohn's Disease, News

A new treatment for Crohn’s disease is showing promise in clinical trials. Giuliani, an Italian pharmaceutical company, conducted a phase 2 clinical study of more than 150 adult patients with Crohn’s disease ... Read more

March 19, 2015March 19, 2015

Samsung Submits MAA for Remicade Biosimilar For Crohn’s Disease, Ulcerative Colitis to EMA

Crohn's Disease, News, Ulcerative colitis

Samsung Bioepis Co. Ltd. recently submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) regarding a biosimilar treatment for several conditions, including Crohn’s disease and ulcerative colitis. The Remicade (Infliximab) ... Read more

March 11, 2015September 28, 2016

Children with Crohn’s Disease Experience Racial Disparities in Healthcare, Study Suggests

Crohn's Disease, News

In a new review entitled “Racial Disparities in Readmission, Complications, and Procedures in Children with Crohn’s Disease” authors describe ethnicity-based decisions in hospital care of children affected by Crohn’s disease. ... Read more

February 18, 2015February 18, 2015

SICUS, MRE, CE are Effective Imaging Techniques for Crohn’s Disease in Children, Comparative Study Shows

Crohn's Disease, News

A research team led by Salvatore Cucciara from the Paediatric Gastroenterology and Liver Unit at the Sapienza University of Rome, Italy recently conducted a prospective comparison blinded study on 25 patients recruited ... Read more

February 17, 2015February 17, 2015

TiGenix And Lonza Partner For Complex Perianal Fistulas In Crohn’s Disease Treatment

Crohn's Disease, News

TiGenix, an advanced biotechnological company committed to developing and marketing new therapeutics from allogeneic expanded adipose-derived stem cells (eASCs) for autoimmune and inflammatory diseases, together with Lonza, a leading and global company of ... Read more